Hypocretin/orexin in arousal and stress

Brain Research

Volumn 1314, Issue , 2010, Pages 91-102

  Berridge, Craig W ^a   España, Rodrigo A ^b   Vittoz, Nicole M ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arousal; Hypocretin; Orexin; Reward; Stress; Waking

Indexed keywords

OREXIN;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; AVERSION; BEHAVIOR; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; METABOLISM; NARCOLEPSY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SLEEP DISORDER; STRESS; WAKEFULNESS;

ANIMALS; AROUSAL; BEHAVIOR, ANIMAL; BRAIN; ENERGY METABOLISM; FEAR; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIMBIC SYSTEM; MOTIVATION; NEUROPEPTIDES; STRESS, PSYCHOLOGICAL;

EID: 75449107169     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.019     Document Type: Article

References (112)

1. Adamantidis A., and de L.L. The hypocretins as sensors for metabolism and arousal. J. Physiol. 587 (2009) 33-40
2. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., and de L.L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450 (2007) 420-424
3. Al Barazanji K.A., Wilson S., Baker J., Jessop D.S., and Harbuz M.S. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol. 13 (2001) 421-424
4. Antelman S.M., Szechtman H., Chin P., and Fisher A.E. Tail pinch-induced eating, gnawing and licking behavior in rats: dependence on the nigrostriatal dopamine system. Brain Res. 99 (1975) 319-337
5. Arnsten A.F. Development of the cerebral cortex. XIV. Stress impairs prefrontal cortical function. J. Am. Acad. Child Adolesc. Psych. 38 (1999) 220-222
6. Arnsten A.F. Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog. Brain Res. 126 (2000) 183-192
7. Arnsten A.F., Berridge C., and Segal D.S. Stress produces opioid-like effects on investigatory behavior. Pharmacol. Biochem. Behav. 22 (1985) 803-809
8. Bayer L., Eggermann E., Serafin M., Saint-Mleux B., Machard D., Jones B., and Muhlethaler M. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci. 14 (2001) 1571-1575
9. Bernardis L.L., and Bellinger L.L. The lateral hypothalamic area revisited: ingestive behavior. Neurosci. Biobehav. Rev. 20 (1996) 189-287
10. Berridge C.W. Noradrenergic modulation of arousal. Brain Res. Rev. 58 (2008) 1-17
11. Berridge C.W., and Dunn A.J. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. J. Neurosci. 9 (1989) 3513-3521
12. Berridge C.W., and Foote S.L. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J. Neurosci. 16 (1996) 6999-7009
13. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Rev. 28 (1998) 309-369
14. Berridge C.W., and O'Neill J. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata. Behav. Neurosci. 115 (2001) 165-174
15. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 42 (2003) 33-84
16. Berridge C.W., and España R.A. Hypocretin/orexin in stress and arousal. In: de Lecea L., and Sutcliffe J.G. (Eds). Hypocretins: integrators of physiological functions (2005), Springer, Singapore 351-368
17. Berridge C.W., Mitton E., Clark W., and Roth R.H. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse 32 (1999) 187-197
18. Bourgin P., Huitron-Resendiz S., Spier A.D., Fabre V., Morte B., Criado J.R., Sutcliffe J.G., Henriksen S.J., and de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20 (2000) 7760-7765
19. Boutrel B., and de Lecea L.L. Addiction and arousal: the hypocretin connection. Physiol. Behav. 93 (2008) 947-951
20. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., and de L.L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19168-19173
21. Brown R.E., Sergeeva O.A., Eriksson K.S., and Haas H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 22 (2002) 8850-8859
22. Buzsaki G., Bickford R.G., Ponomareff G., Thal L.J., Mandel R., and Gage F.H. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J. Neurosci. 8 (1988) 4007-4026
23. Cannon W.B. The emergency function of the adrenal medulla in pain and the major emotions. Am. J. Physiol. 33 (1914) 356-372
24. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
25. Crocker A., Espana R.A., Papadopoulou M., Saper C.B., Faraco J., Sakurai T., Honda M., Mignot E., and Scammell T.E. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65 (2005) 1184-1188
26. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., and Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. 96 (1999) 748-753
27. Deboer T., Overeem S., Visser N.A., Duindam H., Frolich M., Lammers G.J., and Meijer J.H. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 129 (2004) 727-732
28. Dunn A.J. Stress-related activation of cerebral dopaminergic systems. Ann. N.Y. Acad. Sci. 537 (1988) 188-205
29. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Brain Res. Rev. 15 (1990) 71-100
30. Dunn A.J., Guild A.L., Kramarcy N.R., and Ware M.D. Benzodiazepines decrease grooming in response to novelty but not ACTH or beta-endorphin. Pharmacol. Biochem. Behav. 15 (1981) 605-608
31. Dunn A.J., Berridge C.W., Lai Y.I., and Yachabach T.L. CRF-induced excessive grooming behavior in rats and mice. Peptides 8 (1987) 841-844
32. Elmquist J.K., Elias C.F., and Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22 (1999) 221-232
33. Eriksson K.S., Sergeeva O., Brown R.E., and Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21 (2001) 9273-9279
34. España R.A., Baldo B.A., Kelley A.E., and Berridge C.W. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106 (2001) 699-715
35. España R.A., Plahn S., and Berridge C.W. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res. 943 (2002) 224-236
36. España R.A., Valentino R.J., and Berridge C.W. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 121 (2003) 201-217
37. España R.A., Reis K.M., Valentino R.J., and Berridge C.W. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J. Comp. Neurol. 481 (2005) 160-178
38. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., Saper C.B., and Scammell T.E. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21 (2001) 1656-1662
39. Fadel J., Bubser M., and Deutch A.Y. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J. Neurosci. 22 (2002) 6742-6746
40. Gispen W.H., and Isaacson R.L. ACTH-induced excessive grooming in the rat. Pharmacol. Ther. 12 (1981) 209-246
41. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., and Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10911-10916
42. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., and Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30 (2001) 345-354
43. Harris G.C., and Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 29 (2006) 571-577
44. Harris G.C., Wimmer M., and Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (2005) 556-559
45. Harris G.C., Wimmer M., Randall-Thompson J.F., and Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav. Brain Res. 183 (2007) 43-51
46. Hennessy M.B., and Foy T. Nonedible material elicits chewing and reduces the plasma corticosterone response during novelty exposure in mice. Behav. Neurosci. 101 (1987) 237-245
47. Hobson J.A., McCarley R.W., and Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189 (1975) 55-58
48. Hollander J.A., Lu Q., Cameron M.D., Kamenecka T.M., and Kenny P.J. Insular hypocretin transmission regulates nicotine reward. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19480-19485
49. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., and van Den Pol A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415 (1999) 145-159
50. Ida T., Nakahara K., Katayama T., Murakami N., and Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 821 (1999) 526-529
51. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., and Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 270 (2000) 318-323
52. Iuvone P.M., and Dunn A.J. Tyrosine hydroxylase activation in mesocortical 3,4- dihydroxyphenylethylamine neurons following footshock. J. Neurochem. 47 (1986) 837-844
53. Ivanov A., and Aston-Jones G. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. NeuroReport 11 (2000) 1755-1758
54. Jászberényi M., Bujdosó E., Pataki I., and Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J. Neuroendocrinol. 12 (2000) 1174-1178
55. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., Fukuda Y., and Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 285 (2003) R581-R593
56. Kiyashchenko L.I., Mileykovskiy B.Y., Lai Y.Y., and Siegel J.M. Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J. Neurophysiol. 85 (2001) 2008-2016
57. Koob G.F., and Bloom F.E. Corticotropin-releasing factor and behavior. Fed. Proc. 44 (1985) 259-263
58. Koob G.F., Thatcher-Briton K., Tazi A., and Le Moal M. Behavioral pharmacology of stress: focus on CNS corticotropin-releasing factor. Adv. Exp. Med. Biol. 245 (1988) 25-34
59. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., and Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23 (2003) 7-11
60. Kuru M., Ueta Y., Serino R., Nakazato M., Yamamoto Y., Shibuya I., and Yamashita H. Centrally administered orexin/hypocretin activates HPA axis in rats. NeuroReport 11 (2000) 1977-1980
61. Lee M.G., Hassani O.K., and Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 25 (2005) 6716-6720
62. Leri F., Flores J., Rodaros D., and Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J. Neurosci. 22 (2002) 5713-5718
63. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., and Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
64. Lubkin M., and Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 253 (1998) 241-245
65. Malendowicz L.K., Tortorella C., and Nussdorfer G.G. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J. Steroid Biochem. Mol. Biol. 70 (1999) 185-188
66. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., and Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435 (2001) 6-25
67. Marinelli M., and Piazza P.V. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur. J. Neurosci. 16 (2002) 387-394
68. Martins P.J., D'Almeida V., Pedrazzoli M., Lin L., Mignot E., and Tufik S. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul. Pept. 117 (2004) 155-158
69. Mason J.W. The scope of psychoendocrine research. Psychosom. Med. (1968) 565-575
70. Mileykovskiy B.Y., Kiyashchenko L.I., and Siegel J.M. Behavioral correlates of activity in identified hypocreting (orexin) neurons. Neuron 46 (2005) 787-798
71. Mochizuki T., Crocker A., McCormack S., Yanagisawa M., Sakurai T., and Scammell T.E. Behavioral state instability in orexin knock-out mice. J. Neurosci. 24 (2004) 6291-6300
72. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., and Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 26 (2006) 398-405
73. Narita M., Nagumo Y., Miyatake M., Ikegami D., Kurashi K., and Suzuki T. Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur. J. Neurosci. 25 (2007) 1537-1545
74. Nishino S., Ripley B., Overeem S., Lammers G.J., and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
75. Nowak K.W., Mackowiak P., Switonska M.M., Fabis M., and Malendowicz L.K. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci. 66 (2000) 449-454
76. Peyron C., Tighe D.K., van Den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., and Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18 (1998) 9996-10015
77. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., and Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6 (2000) 991-997
78. Piper D.C., Upton N., Smith M.I., and Hunter A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12 (2000) 726-730
79. Ripley B., Overeem S., Fujiki N., Nevsimalova S., Uchino M., Yesavage J., Di Monte D., Dohi K., Melberg A., Lammers G.J., Nishida Y., Roelandse F.W., Hungs M., Mignot E., and Nishino S. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57 (2001) 2253-2258
80. Robbins T.W. Cortical noradrenaline, attention and arousal. Psychol. Med. 14 (1984) 13-21
81. Sakamoto F., Yamada S., and Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 118 (2004) 183-191
82. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 1
83. Sakurai T., Moriguchi T., Furuya K., Kajiwara N., Nakamura T., Yanagisawa M., and Goto K. Structure and function of human prepro-orexin gene. J. Biol. Chem. 274 (1999) 17771-17776
84. Samson W.K., Gosnell B., Chang J.K., Resch Z.T., and Murphy T.C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 831 (1999) 248-253
85. Samson W.K., Taylor M.M., Follwell M., and Ferguson A.V. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul. Pept. 104 (2002) 97-103
86. Samson W.K., Bagley S.L., Ferguson A.V., and White M.M. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am. J. Physiol., Regul. Integr. Comp. Physiol 292 (2007) R382-R387
87. Selye H. The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol. Metab. 6 (1946) 117-230
88. Selye H. Confusion and controversy in the stress field. J. Hum. Stress 1 (1975) 37-44
89. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., and Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277 (1999) R1780-R1785
90. Shirasaka T., Miyahara S., Kunitake T., Jin Q.H., Kato K., Takasaki M., and Kannan H. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am. J. Physiol., Regul. Integr. Comp. Physiol 281 (2001) R1114-R1118
91. Smith B.N., Davis S.F., van Den Pol A.N., and Xu W. Selective enhancement of excitatory synaptic activity in the rat nucleus tractus solitarius by hypocretin 2. Neuroscience 115 (2002) 707-714
92. Smith P.M., Connolly B.C., and Ferguson A.V. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res. 950 (2002) 261-267
93. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J. Psychiatry Neurosci. 25 (2000) 125-136
94. Stone E.A. Effect of stress on norepinephrine-stimulated cyclic AMP formation in brain slices. Pharmacol. Biochem. Behav. 8 (1978) 583-591
95. Sutcliffe J.G., and de Lecea L. The hypocretins: setting the arousal threshold. Nat. Rev., Neurosci. 3 (2002) 339-349
96. Taheri S., Mahmoodi M., Opacka-Juffry J., Ghatei M.A., and Bloom S.R. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett. 457 (1999) 157-161
97. Teske J.A., Billington C.J., and Kotz C.M. Neuropeptidergic mediators of spontaneous physical activity and non-exercise activity thermogenesis. Neuroendocrinology 87 (2008) 71-90
98. Thakkar M.M., Ramesh V., Strecker R.E., and McCarley R.W. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139 (2001) 313-328
99. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., and Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 469-474
100. Thierry A.M., Tassin J.P., Blanc G., and Glowinski J. Selective activation of mesocortical DA system by stress. Nature 263 (1976) 242-244
101. Torterolo P., Yamuy J., Sampogna S., Morales F.R., and Chase M.H. Hypocretinergic neurons are primarily involved in activation of the somatomotor system. Sleep 26 (2003) 25-28
102. Tsuda A., Tanaka M., Ida Y., Shirao I., Gondoh Y., Oguchi M., and Yoshida M. Expression of aggression attenuates stress-induced increases in rat brain noradrenaline turnover. Brain Res. 474 (1988) 174-180
103. van den Pol T.M., Nolan M.F., Lee K., Richardson P.J., Buijs R.M., Davies C.H., and Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J. Physiol. 549 (2003) 809-821
104. Vittoz N.M., and Berridge C.W. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 31 (2006) 384-395
105. Vittoz N.M., Schmeichel B., and Berridge C.W. Hypocretin/orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur. J. Neurosci. 28 (2008) 1629-1640
106. Weinshenker D., and Schroeder J.P. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32 (2007) 1433-1451
107. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., and Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38 (2003) 701-713
108. Yerkes R.M., and Dodson J.D. The relation of strength of stimulus to rapidity of habit-formation. J. Comp. Neurol. Psychol. 18 (1908) 459-482
109. Yoshida Y., Fujiki N., Nakajima T., Ripley B., Matsumura H., Yoneda H., Mignot E., and Nishino S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14 (2001) 1075-1081
110. Yoshimichi G., Yoshimatsu H., Masaki T., and Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp. Biol. Med. 226 (2001) 468-476
111. Zeitzer J.M., Buckmaster C.L., Parker K.J., Hauck C.M., Lyons D.M., and Mignot E. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J. Neurosci. 23 (2003) 3555-3560
112. Zhu L., Onaka T., Sakurai T., and Yada T. Activation of orexin neurones after noxious but not conditioned fear stimuli in rats. NeuroReport 13 (2002) 1351-1353